Pacific Biosciences of California, Inc. Sales Revenue, Goods, Gross (Deprecated 2018-01-31)
Pacific Biosciences of California, Inc. (PACB) reported Sales Revenue, Goods, Gross (Deprecated 2018-01-31) of $8.71 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsGross · last filed 2012-05-07
- Pacific Biosciences of California, Inc. sales revenue, goods, gross (deprecated 2018-01-31) for the quarter ending 2012-03-31 was $8.71M.
- Pacific Biosciences of California, Inc. sales revenue, goods, gross (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $11.52M.
- Pacific Biosciences of California, Inc. sales revenue, goods, gross (deprecated 2018-01-31) for the quarter ending 2011-09-30 was $9.82M.
- Pacific Biosciences of California, Inc. sales revenue, goods, gross (deprecated 2018-01-31) for the quarter ending 2011-06-30 was $10.15M.
- Pacific Biosciences of California, Inc. sales revenue, goods, gross (deprecated 2018-01-31) for fiscal 2011 was $31.49M.
| Period end | Sales Revenue, Goods, Gross (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Gross (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Gross (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Gross (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2012-03-31 | $8.71M 10-Q · filed 2012-05-07 | $20.23M derived: sum of 2 quarters · filed 2012-05-07 | $30.05M derived: sum of 3 quarters · filed 2012-05-07 | $40.20M derived: sum of 4 quarters · filed 2012-05-07 |
| 2011-12-31 | $11.52M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-01 | $21.34M derived: sum of 2 quarters · filed 2012-03-01 | $31.49M derived: sum of 3 quarters · filed 2012-03-01 | $31.49M 10-K · filed 2012-03-01 |
| 2011-09-30 | $9.82M 10-Q · filed 2011-11-14 | $19.97M derived: sum of 2 quarters · filed 2011-11-14 | $19.97M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $10.15M 10-Q · filed 2011-08-12 | $10.15M 10-Q · filed 2011-08-12 | ||
| 2011-03-31 | -$1.00K derived: 10-K 12 month − 3 quarters · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |